ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model March 24, 2026 Partnership will integrate ICON’s clinical trial technology with Advarra’s purpose-built system for research sites, embedded across a broad, deeply established global network. Partnership will reduce administrative friction, accelerate study startup, and increase clinical trial participation.
Kaplan Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 for AI-Powered Educational Products March 24, 2026 Kaplan has been recognized as one of the World’s Most Innovative Companies of 2026 by Fast Company. This award highlights Kaplan’s leadership in artificial intelligence (AI) across three key areas: personalized admissions counseling, adaptive independent study, and scalable technical feedback. Summary of Kaplan’s AI Innovations: AI College Admissions Tool: KapAdvisor™ Premium for Parents reduces family [...]
Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights March 24, 2026 COMP360 is the first classic psychedelic1 to consistently achieve a highly statistically significant result and clinically meaningful effect in treatment resistant depression (TRD), with a generally well-tolerated and safe profile Across three large trials in TRD, including two positive Phase 3 studies, COMP360’s differentiated profile is redefining rapidity and durability for TRD patients and demonstrating a consistent level of clinical effect that has never been achieved before Compass will meet with the FDA to confirm alignment on a rolling submission and review, and expects to complete the NDA submission in Q4 Compass is rapidly advancing commercial readiness plans and expects COMP360 will fit seamlessly across diverse healthcare settings at launch Phase 2b/3 trial in PTSD initiating, following FDA acceptance of IND application Successful $150 million financing in February and exercise of $200 million in warrants extends cash runway into 2028
TPG and Allianz Lead USD 350 Million Strategic Investment in Cambridge Mobile Telematics to Accelerate AI-Driven Road Safety March 24, 2026 Partnership to Expand Global Road Safety Platform and Real-Time AI Risk Models Accompanied by New Long-Term Commercial Agreements Between Allianz and CMT
Carta Launches Unified Fund of Funds Solution to Automate LP Workflows and Portfolio Visibility March 24, 2026 New AI-powered offering closes the gap between investment data and investor reporting, bringing institutional-grade automation to complex Fund of Funds structures
New Diffblue Testing Agent Automatically Generates Comprehensive Regression Test Suites To Derisk Application Modernization March 24, 2026 Published benchmark research from generative AI coding pioneer quantifies compelling advantages of new solution’s end-to-end process automation over stand-alone coding agents
Ada Study Finds Consumers Prefer “Always-On” AI Customer Service, But Only When It Can Successfully Resolve Their Issue March 24, 2026 New global research conducted with NewtonX reveals major misalignment between what enterprises prioritize and what consumers value in agentic customer experience
OCTO and Volkswagen Group Info Services AG Form Partnership for Fleet Data Integration March 24, 2026 The partnership enables secure integration of vehicle data from six Volkswagen Group brands into OCTO’s platform, strengthening fleet data services across the European Union and supporting utilization, maintenance and geo-location use cases without additional hardware.
Aptia and UST Earn ISG Paragon Award for Transformative Partnership March 24, 2026 Partnership paves the way for disrupting traditional QA models
Pepper Advantage Launches Strategic Servicing Solution for Institutional Credit Portfolios March 24, 2026 New offering launched in pilot with tier-one global investment fund; provides independent governance and technology-enabled oversight of portfolios across Europe and the UK
